Managing Director

David S. Frank, Ph. D. has over 38 years experience in health care.  Following two years on the faculty of SUNY Downstate Medical Center, he joined the nascent project group at Eastman Kodak Company which was tasked with developing clinical diagnostic tests in a coated, thin-film format.  As a scientist and group leader there he focused on thin-film immunoassay and cellular assays, and was awarded 10 patents by the US PTO.  

He spent the next 14 years at Kodak is a series of more responsible positions in international marketing and strategic planning.  They included: The launch of thin film products in Japan, Regional Business General Manager of the Asia, Africa and Australasia Business Unit, and management of the highly profitable, $80 MM, point-of-care diagnostics business.  In that role he negotiated Kodak’s strategic alliance with IDEXX which leveraged the human IVD line into the veterinary market.

After the sale of the Kodak Diagnostic business to Johnson & Johnson in late 1994, he moved into Business Development at Ortho Clinical Diagnostics and consummated over 50 deals-- acquisitions, divestitures, in and out licenses.  Most notable was the strategic alliance with IMMUNICON that spring- boarded the Veridex subsidiary into cellular oncology.  He also liaised with J&J businesses in medical devices (Cordis, Ethicon) and with the Consumer franchise.

Founding MEDx Associates llc  in 2007, he developed a diverse client base located in the US, Canada, Europe and Israel.

For the past five years he has lectured at the LAHAV-Tel Aviv University short course for biomed-biotech entrepreneurs.